Cystic Fibrosis

>

Latest News

FDA approves brensocatib to treat adolescents with non-cystic fibrosis bronchiectasis | Image credit: Contemporary Pediatrics
FDA approves brensocatib to treat adolescents with non–cystic fibrosis bronchiectasis

August 12th 2025

Brensocatib was granted FDA priority review in February 2025 for the small molecule, oral, reversible inhibitor.

doctor checking on patient with stethoscope
How cystic fibrosis can manifest in the gastrointestinal system

February 17th 2020

February 2020 cover image for Contemporary Pediatrics
Gastrointestinal manifestations of cystic fibrosis: A primer for pediatricians

February 13th 2020

collection of pharmaceuticals
Triple combination therapy for cystic fibrosis is here!

February 10th 2020

© 2025 MJH Life Sciences

All rights reserved.